Ding, X., & Sharan, S. K. (2017). Synthetic lethality vs. synthetic viability due to PARP1 and BRCA2 loss. Transl Cancer Res.
Citación estilo ChicagoDing, Xia, and Shyam K. Sharan. "Synthetic Lethality Vs. Synthetic Viability Due to PARP1 and BRCA2 Loss." Transl Cancer Res 2017.
Cita MLADing, Xia, and Shyam K. Sharan. "Synthetic Lethality Vs. Synthetic Viability Due to PARP1 and BRCA2 Loss." Transl Cancer Res 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.